AzTrials
AzTrials

Cerebral Palsy, SpasticNCT05557305

Changes in Motor and Cognitive Function on Unilateral Spastic Cerebral Palsy, Associated With Videogame Therapy

A study testing Videogame therapy and Conventional therapy in people with Cerebral Palsy, Spastic and Hemiplegia, Spastic, run by Universidad Nacional Autonoma de Mexico at 1 site in Mexico.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The use of interactive applications associated with position and movement sensors has begun to spread as an option for the reinforcement of physical rehabilitation therapies in patients with congenital or acquired motor disorders as a result of some neurological damage, due to its portability and the relative autonomy… Read more about this study

Who is it for?
Ages 5 to 18 years
Conditions the study is for
Cerebral Palsy, Spastic, Hemiplegia, Spastic
What is being tested?
Videogame therapy and Conventional therapy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
84 participants
Where
1 siteMexico
Study dates
22 Dec 2022to Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Outpatients
  • Both genders
  • Reside in Mexico City and the metropolitan area
  • Between 5 and 18 years old
  • With upper extremity hemiparesis caused by Unilateral Spastic Cerebral Palsy (USCP) on their dominant side or not
  • Who are at levels I-III of the Manual Ability Classification System for Children with Cerebral Palsy (MACS)
  • Score equal to or greater than 20 on the Fugl-Meyer upper extremity scale.

Who cannot join

  • Patients with joint instability (shoulder, elbow, or wrist)
  • With severe concomitant medical problems such as congestive heart failure or seizures that prevent adequate attention to the task.
  • Severe aphasia
  • Hemineglect
  • Visual disturbances that are not corrected with glasses
  • Uncompensated hearing impairment
  • Inability to understand instructions (Token Test < 17)
  • Patients receiving concurrent therapies.

Trial locations and contacts

1 site in 1 country.

Ana María Escalante-Gonzalbo, MCompSci contact

525556225730

aescalan@ifc.unam.mx

Eduardo Espinosa-Garamendi, PhD contact

525635280056

eduardogaramendi@hotmail.com

Mexico1 site, 1 recruiting
  • Instituto Nacional de Pediatría

    Mexico City, Coyoacán, CDMX, 04530

    Ana Maria Escalante-Gonzalbo, MCSc, 5556225730, aescalan@ifc.unam.mx

    Recruiting

Other trials in Mexico

About this study

Official title: Evaluation of the Usability, Safety, and Possible Beneficial Effects on Motor and Cognitive Functions Associated With Using a Neuro-rehabilitation Platform With Video Games in Pediatric Patients With Unilateral Spastic Cerebral Palsy

The use of interactive applications associated with position and movement sensors has begun to spread as an option for the reinforcement of physical rehabilitation therapies in patients with congenital or acquired motor disorders as a result of some neurological damage, due to its portability and the relative autonomy granted to the patient. However, the results of its effectiveness and impact continue to be scarce compared to the traditional therapy used for rehabilitation. The aim of this study is to explore possible benefits associated with occupational therapy with video games in patients with unilateral spastic cerebral palsy, comparing them with conventional therapy.

A randomized pilot study will be carried out, with a control group. The intervention will consist of the application of a virtual rehabilitation program for the experimental group while the control group will receive only conventional therapy. Before and after the said intervention, standardized tests will be applied to evaluate both motor function and the cognitive performance of the participants.

Read the detailed description

This intervention protocol aims to validate five interactive applications for neurorehabilitation, as an effective therapeutic complement for the rehabilitation of children with unilateral cerebral palsy, compared to conventional rehabilitation.

The intervention contemplates first a phase of application of standardized tests in the Cognitive enablement lab of the National Institute of pediatrics (INP) in Mexico City, to determine, among other things, if the patient meets the established inclusion criteria. Patients who meet these criteria will be randomly assigned to the control or experimental group.

In the same INP, standardized tests will be applied to record their motor and cognitive capacity at the beginning of the protocol. Patients in the experimental group will receive two 50-minute video game rehabilitation sessions per week, for 10 weeks, under the supervision of trained personnel from the Laboratory of Applications for Neurorehabilitation (LANR). Control group patients will receive 10 weeks of occupational therapy, as prescribed by their treating physician.

All standardized tests will be applied again to the participants of both groups after the 10 weeks of intervention, and again six months later, to measure the persistence of the changes.

In the case of the experimental group, five interactive applications will be tested, each with a different sensor and virtual environment, as well as its own therapeutic objective, these applications are part of the National Autonomous University of Mexico (UNAM) virtual rehabilitation platform.

Being tested
Videogame therapy, Conventional therapy
Keywords
virtual rehabilitation, video games, motor function, spastic hemiparesis, cerebral palsy, unilateral spastic cerebral palsy
Medical subject headings
Cerebral Palsy, Hemiplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Videogame therapyDevice

    Also called Virtual rehabilitation

    There will be 5 video game-type applications for virtual therapy, each with a specific therapeutic objective, which will be administered by trained personnel, depending on the characteristics of each patient.

  • Conventional therapyOther

    Also called Occupational therapy

    Occupational therapy with different play materials

Study groups in NCT05557305
Study groupRoleWhat they receive
Videogame therapyExperimentalThe participants of the experimental group will only undergo video game therapy and will be called twice a week to perform supervised video game rehabilitation therapy, for a period of 45-50 minutes per session, for 10 weeks
Receives: Device: Videogame therapy
Conventional therapyActive comparatorThe participants in the control group will undergo the conventional therapy prescribed by their treating physician, at the INP they are prescribed occupational therapy, which is usually focused on game activities with balls, dice, cubes, tying ropes, etc., twice a week for 10 weeks.
Receives: Other: Conventional therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in the Fugl-Meyer Assesment for upper extremity (FMUE)

    Level of motor deficit, evaluated using the Fugl-Meyer Assessment scale for the upper limb (0-66), with 66 meaning no defficit.

    Measured: Baseline, 10 Weeks, 6 months

  2. Change in the Quality of Upper Extremity Skills Test (QUEST)

    Upper limb motor skill level, obtained through the Quality of Upper Extremity Skills Test (less than 0 to 100), with 100 being the best quality of movement.

    Measured: Baseline, 10 Weeks, 6 months

Secondary outcomes (5)
  1. Change in the PedsQl pediatric quality of life questionnaire

    Level of independence in performing activities of daily living (ADLs), assessed using the PedsQl pediatric quality of life questionnaire (0-132) with 0 as the highest score.

    Measured: Baseline, 10 Weeks, 6 months

  2. Change in the digital version of the Trail Making Test (TMT-A)

    Changes in cognitive function in terms of speed of executive functions and attention, measured by a digitized version of the Trail Making Test A.

    Measured: Baseline, 10 Weeks, 6 months

  3. Change in the digital version of the Corsi cube test.

    Changes in working memory measured by the Corsi Cubes test.

    Measured: Baseline, 10 Weeks, 6 months

  4. Change in the digital version of the Perception of differences test (FACES)

    Changes in visual perception, using the perception of differences test

    Measured: Baseline, 10 Weeks, 6 months

  5. Change in the Digital implementation of the Go-NoGo paradigm.

    Changes in inhibition and flexibility functions, measured using a digital implementation of the Go-NoGo paradigm

    Measured: Baseline, 10 Weeks, 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2022
  2. Study start22 Dec 2022
  3. Primary completionMay 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Pilot, randomized, controlled, longitudinal trial
Masking
None (open label)
Enrolment
84 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05557305
Sponsor's protocol ID
2022/054
Status last verified
May 2024
First submitted
21 Sep 2022
Last updated
7 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Escalante-Gonzalbo AM, Ramirez-Graullera YS, Pasantes H, Aguilar-Chale JJ, Sanchez-Castillo GI, Escutia-Macedo XA, Briseno-Soriano TM, Franco-Castro P, Estrada-Rosales AL, Vazquez-Abundes SE, Andrade-Morales D, Hernandez-Franco J, Palafox L. Safety, Feasibility, and Acceptability of a New Virtual Rehabilitation Platform: A Supervised Pilot Study. Rehabil Process Outcome. 2021 Aug 7;10:11795727211033279. doi: 10.1177/11795727211033279. eCollection 2021.

    PubMed 34987304

Questions about this trial

What is this clinical trial studying?

A study testing Videogame therapy and Conventional therapy in people with Cerebral Palsy, Spastic and Hemiplegia, Spastic, run by Universidad Nacional Autonoma de Mexico at 1 site in Mexico.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Mexico. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ana María Escalante-Gonzalbo, MCompSci (525556225730, aescalan@ifc.unam.mx), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in the Fugl-Meyer Assesment for upper extremity (FMUE) (time frame: Baseline, 10 Weeks, 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05557305, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in